{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,18]],"date-time":"2025-11-18T01:31:59Z","timestamp":1763429519453},"reference-count":146,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2018,7,1]],"date-time":"2018-07-01T00:00:00Z","timestamp":1530403200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","theclinics.com","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinics in Dermatology"],"published-print":{"date-parts":[[2018,7]]},"DOI":"10.1016\/j.clindermatol.2018.04.010","type":"journal-article","created":{"date-parts":[[2018,4,10]],"date-time":"2018-04-10T16:26:30Z","timestamp":1523377590000},"page":"533-550","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Inflammatory arthritis and crystal arthropathy: Current concepts of skin and systemic manifestations"],"prefix":"10.1016","volume":"36","author":[{"given":"Mahdieh","family":"Fazel","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joseph F.","family":"Merola","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Drew J.B.","family":"Kurtzman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.clindermatol.2018.04.010_bb0005","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/j.clindermatol.2010.09.021","article-title":"Skin signs of systemic diseases","volume":"29","author":"Rigopoulos","year":"2011","journal-title":"Clin Dermatol"},{"key":"10.1016\/j.clindermatol.2018.04.010_bb0010","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1007\/s12016-017-8632-5","article-title":"Skin manifestations of rheumatoid arthritis, juvenile idiopathic arthritis, and spondyloarthritides","volume":"53","author":"Chua-Aguilera","year":"2017","journal-title":"Clin Rev Allergy Immunol"},{"key":"10.1016\/j.clindermatol.2018.04.010_bb0015","first-page":"S295","article-title":"Overview of epidemiology, pathophysiology, and diagnosis of rheumatoid arthritis","volume":"18","author":"Gibofsky","year":"2012","journal-title":"Am J Manag Care"},{"key":"10.1016\/j.clindermatol.2018.04.010_bb0020","doi-asserted-by":"crossref","first-page":"2205","DOI":"10.1056\/NEJMra1004965","article-title":"The pathogenesis of rheumatoid arthritis","volume":"365","author":"McInnes","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/j.clindermatol.2018.04.010_bb0025","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1093\/rheumatology\/38.7.668","article-title":"Extra-articular rheumatoid arthritis: prevalence and mortality","volume":"38","author":"Turesson","year":"1999","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.clindermatol.2018.04.010_bb0030","doi-asserted-by":"crossref","first-page":"983","DOI":"10.3899\/jrheum.101133","article-title":"Incidence of extraarticular rheumatoid arthritis in Olmsted County, Minnesota, in 1995-2007 versus 1985-1994: a population-based study","volume":"38","author":"Myasoedova","year":"2011","journal-title":"J Rheumatol"},{"key":"10.1016\/j.clindermatol.2018.04.010_bb0035","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1186\/ar95","article-title":"Citrullination: a small change for a protein with great consequences for rheumatoid arthritis","volume":"2","author":"van Venrooij","year":"2000","journal-title":"Arthritis Res"},{"key":"10.1016\/j.clindermatol.2018.04.010_bb0040","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1136\/ard.2010.139527","article-title":"Different stages of rheumatoid arthritis: features of the synovium in the preclinical phase","volume":"70","author":"van de Sande","year":"2011","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.clindermatol.2018.04.010_bb0045","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.jaad.2004.07.023","article-title":"Rheumatoid arthritis: a review of the cutaneous manifestations","volume":"53","author":"Sayah","year":"2005","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2018.04.010_bb0050","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.berh.2004.08.006","article-title":"Imaging in early rheumatoid arthritis: roles of magnetic resonance imaging, ultrasonography, conventional radiography and computed tomography","volume":"19","author":"Ostergaard","year":"2005","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"10.1016\/j.clindermatol.2018.04.010_bb0055","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1016\/j.rcl.2017.04.006","article-title":"Computed tomography and MR imaging in rheumatoid arthritis","volume":"55","author":"Barile","year":"2017","journal-title":"Radiol Clin N Am"},{"issue":"suppl 7","key":"10.1016\/j.clindermatol.2018.04.010_bb0060","doi-asserted-by":"crossref","first-page":"vii36","DOI":"10.1093\/rheumatology\/kes329","article-title":"Imaging tools in rheumatoid arthritis: ultrasound vs magnetic resonance imaging","volume":"51","author":"Tan","year":"2012","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.clindermatol.2018.04.010_bb0065","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/j.rbr.2015.11.002","article-title":"Analysis of four serum biomarkers in rheumatoid arthritis: association with extra articular manifestations in patients and arthralgia in relatives","volume":"57","author":"Nass","year":"2017","journal-title":"Rev Bras Reumatol Engl Ed"},{"key":"10.1016\/j.clindermatol.2018.04.010_bb0070","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1056\/NEJMra1505557","article-title":"Psoriatic Arthritis","volume":"376","author":"Ritchlin","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/j.clindermatol.2018.04.010_bb0075","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1007\/s00393-015-1598-x","article-title":"Diagnostic accuracy of anti-MCV and anti-CCP antibodies in rheumatoid arthritis: a meta-analysis","volume":"74","author":"Lee","year":"2015","journal-title":"Z Rheumatol"},{"key":"10.1016\/j.clindermatol.2018.04.010_bb0080","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1136\/ard.2003.014647","article-title":"Decrease of anti-cyclic citrullinated peptide antibodies and rheumatoid factor following anti-TNFalpha therapy (infliximab) in rheumatoid arthritis is associated with clinical improvement","volume":"63","author":"Alessandri","year":"2004","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.clindermatol.2018.04.010_bb0085","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1097\/00005792-199069020-00001","article-title":"The Felty syndrome: a case-matched study of clinical manifestations and outcome, serologic features, and immunogenetic associations","volume":"69","author":"Campion","year":"1990","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.clindermatol.2018.04.010_bb0090","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1136\/ard.36.6.500","article-title":"Felty\u2019s syndrome. Clinical and serological analysis of 34 cases","volume":"36","author":"Sienknecht","year":"1977","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.clindermatol.2018.04.010_bb0095","first-page":"507","article-title":"The frequency of leg ulceration in rheumatoid arthritis: a survey","volume":"10","author":"Thurtle","year":"1983","journal-title":"J Rheumatol"},{"key":"10.1016\/j.clindermatol.2018.04.010_bb0100","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1097\/MOH.0b013e32834760fb","article-title":"The spectrum of large granular lymphocyte leukemia and Felty\u2019s syndrome","volume":"18","author":"Liu","year":"2011","journal-title":"Curr Opin Hematol"},{"key":"10.1016\/j.clindermatol.2018.04.010_bb0105","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1111\/j.1365-2249.1995.tb02271.x","article-title":"Large granular lymphocyte expansions in patients with Felty\u2019s syndrome: analysis using anti-T cell receptor V beta-specific monoclonal antibodies","volume":"101","author":"Bowman","year":"1995","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.clindermatol.2018.04.010_bb0110","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1016\/j.jaad.2005.02.032","article-title":"Histopathology of persistent papules and plaques in adult-onset Still\u2019s disease","volume":"52","author":"Lee","year":"2005","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2018.04.010_bb0115","first-page":"427","article-title":"\u201cAdolescent-onset Still\u2019s disease\u201d: characteristics and outcome in comparison with adult-onset Still\u2019s disease","volume":"20","author":"Luthi","year":"2002","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.clindermatol.2018.04.010_bb0120","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1136\/ard.49.5.283","article-title":"Comparison of long term evolution of adult onset and juvenile onset Still\u2019s disease, both followed up for more than 10 years","volume":"49","author":"Cabane","year":"1990","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.clindermatol.2018.04.010_bb0125","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1007\/BF01451062","article-title":"Still\u2019s disease in children and adults: a distinct pattern of acute-phase proteins","volume":"17","author":"Sobieska","year":"1998","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.clindermatol.2018.04.010_bb0130","doi-asserted-by":"crossref","first-page":"2233","DOI":"10.1007\/s00296-011-2330-z","article-title":"Cutaneous manifestations associated with adult-onset Still\u2019s disease: important diagnostic values","volume":"32","author":"Yamamoto","year":"2012","journal-title":"Rheumatol Int"},{"key":"10.1016\/j.clindermatol.2018.04.010_bb0135","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1136\/ard.47.9.764","article-title":"Adult onset Still\u2019s disease and viral infections","volume":"47","author":"Wouters","year":"1988","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.clindermatol.2018.04.010_bb0140","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1016\/S0140-6736(75)93136-0","article-title":"Rubella-virus infection in juvenile rheumatoid arthritis","volume":"1","author":"Ogra","year":"1975","journal-title":"Lancet"},{"key":"10.1016\/j.clindermatol.2018.04.010_bb0145","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1136\/ard.34.4.354","article-title":"Rubella antibody levels in juvenile rheumatoid arthritis","volume":"34","author":"Linnemann","year":"1975","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.clindermatol.2018.04.010_bb0150","first-page":"1507","article-title":"Adult-onset Still\u2019s disease","volume":"120","author":"Harth","year":"1979","journal-title":"Can Med Assoc J"},{"key":"10.1016\/j.clindermatol.2018.04.010_bb0155","first-page":"1275","article-title":"Adult-onset Still\u2019s disease: an unusual presentation of rubella infection","volume":"122","author":"Huang","year":"1980","journal-title":"Can Med Assoc J"},{"key":"10.1016\/j.clindermatol.2018.04.010_bb0160","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1136\/ard.42.1.2","article-title":"Chronic arthritis associated with the presence of intrasynovial rubella virus","volume":"42","author":"Grahame","year":"1983","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.clindermatol.2018.04.010_bb0165","doi-asserted-by":"crossref","first-page":"2496","DOI":"10.1001\/jama.1976.03260490014011","article-title":"Coxsackievirus and adenovirus infection. Association with acute febrile and juvenile rheumatoid arthritis","volume":"235","author":"Rahal","year":"1976","journal-title":"JAMA"},{"key":"10.1016\/j.clindermatol.2018.04.010_bb0170","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1136\/ard.44.5.341","article-title":"Still\u2019s disease associated with Coxsackie infection and haemophagocytic syndrome","volume":"44","author":"Heaton","year":"1985","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.clindermatol.2018.04.010_bb0175","doi-asserted-by":"crossref","first-page":"45","DOI":"10.7326\/0003-4819-97-1-45","article-title":"Mumps arthritis: unusual presentation as adult Still\u2019s disease","volume":"97","author":"Gordon","year":"1982","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.clindermatol.2018.04.010_bb0180","first-page":"1908","article-title":"Mycoplasmosis and Still syndrome. Is there an etiologic connection?","volume":"123","author":"Dold","year":"1981","journal-title":"MMW Munch Med Wochenschr"},{"key":"10.1016\/j.clindermatol.2018.04.010_bb0185","doi-asserted-by":"crossref","first-page":"1880","DOI":"10.1001\/archinte.1984.00350210210040","article-title":"Adult Still\u2019s disease caused by Yersinia enterocolitica infection","volume":"144","author":"Colebunders","year":"1984","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.clindermatol.2018.04.010_bb0190","first-page":"396","article-title":"Elevated serum interleukin 6, interferon-gamma, and tumor necrosis factor-alpha levels in patients with adult Still\u2019s disease","volume":"25","author":"Hoshino","year":"1998","journal-title":"J Rheumatol"},{"key":"10.1016\/j.clindermatol.2018.04.010_bb0195","doi-asserted-by":"crossref","first-page":"1716","DOI":"10.1002\/1529-0131(200107)44:7<1716::AID-ART298>3.0.CO;2-I","article-title":"Interleukin-18 as a novel diagnostic marker and indicator of disease severity in adult-onset Still\u2019s disease","volume":"44","author":"Kawaguchi","year":"2001","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.clindermatol.2018.04.010_bb0200","first-page":"748","article-title":"Adult Still\u2019s disease: part I. Manifestations and complications in sixty-five cases in France","volume":"62","author":"Masson","year":"1995","journal-title":"Rev Rhum Engl Ed"},{"key":"10.1016\/j.clindermatol.2018.04.010_bb0205","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1097\/00005792-199103000-00004","article-title":"Adult Still\u2019s disease: manifestations, disease course, and outcome in 62 patients","volume":"70","author":"Pouchot","year":"1991","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.clindermatol.2018.04.010_bb0210","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1186\/s12916-016-0738-8","article-title":"Adult-onset Still\u2019s disease: evaluation of prognostic tools and validation of the systemic score by analysis of 100 cases from three centers","volume":"14","author":"Ruscitti","year":"2016","journal-title":"BMC Med"},{"key":"10.1016\/j.clindermatol.2018.04.010_bb0215","doi-asserted-by":"crossref","first-page":"1596","DOI":"10.1136\/ard.2005.046904","article-title":"Reactive haemophagocytic syndrome in adult-onset Still\u2019s disease: a report of six patients and a review of the literature","volume":"65","author":"Arlet","year":"2006","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.clindermatol.2018.04.010_bb0220","doi-asserted-by":"crossref","first-page":"e451","DOI":"10.1097\/MD.0000000000000451","article-title":"Reactive hemophagocytic syndrome in adult-onset Still disease: clinical features, predictive factors, and prognosis in 21 patients","volume":"94","author":"Bae","year":"2015","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.clindermatol.2018.04.010_bb0225","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1136\/ard.2005.042143","article-title":"Diagnosis and management of adult onset Still\u2019s disease","volume":"65","author":"Efthimiou","year":"2006","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.clindermatol.2018.04.010_bb0230","first-page":"424","article-title":"Preliminary criteria for classification of adult Still\u2019s disease","volume":"19","author":"Yamaguchi","year":"1992","journal-title":"J Rheumatol"},{"key":"10.1016\/j.clindermatol.2018.04.010_bb0235","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.semarthrit.2017.06.006","article-title":"Adult onset Still\u2019s disease-The evidence that anti-interleukin-1 treatment is effective and well-tolerated (a comprehensive literature review)","volume":"47","author":"Junge","year":"2017","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.clindermatol.2018.04.010_bb0240","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/j.jare.2017.04.008","article-title":"Gout: an old disease in new perspective - a review","volume":"8","author":"Ragab","year":"2017","journal-title":"J Adv Res"},{"key":"10.1016\/j.clindermatol.2018.04.010_bb0245","doi-asserted-by":"crossref","first-page":"3136","DOI":"10.1002\/art.30520","article-title":"Prevalence of gout and hyperuricemia in the US general population: the National Health and Nutrition Examination Survey 2007-2008","volume":"63","author":"Zhu","year":"2011","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.clindermatol.2018.04.010_bb0250","doi-asserted-by":"crossref","DOI":"10.1007\/s11926-017-0688-y","article-title":"Gout and metabolic syndrome: a tangled web","volume":"19","author":"Thottam","year":"2017","journal-title":"Curr Rheumatol Rep"},{"key":"10.1016\/j.clindermatol.2018.04.010_bb0255","doi-asserted-by":"crossref","first-page":"499","DOI":"10.7326\/0003-4819-143-7-200510040-00009","article-title":"Pathogenesis of gout","volume":"143","author":"Choi","year":"2005","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.clindermatol.2018.04.010_bb0260","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1038\/nrrheum.2015.91","article-title":"Global epidemiology of gout: prevalence, incidence and risk factors","volume":"11","author":"Kuo","year":"2015","journal-title":"Nat Rev Rheumatol"},{"key":"10.1016\/j.clindermatol.2018.04.010_bb0265","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/0002-9343(87)90441-4","article-title":"Asymptomatic hyperuricemia. Risks and consequences in the Normative Aging Study","volume":"82","author":"Campion","year":"1987","journal-title":"Am J Med"},{"key":"10.1016\/j.clindermatol.2018.04.010_bb0270","first-page":"942","article-title":"Acute gout attack with normal serum uric acid levels","volume":"118","author":"Badulescu","year":"2014","journal-title":"Rev Med Chir Soc Med Nat Iasi"},{"key":"10.1016\/j.clindermatol.2018.04.010_bb0275","first-page":"39","article-title":"Pathogenesis and treatment of crystal-induced inflammation","volume":"vol. 2303","author":"Terkeltaub","year":"2005"},{"key":"10.1016\/j.clindermatol.2018.04.010_bb0280","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1093\/rheumatology\/33.8.731","article-title":"Impaired lipoprotein metabolism in patients with primary gout\u2014influence of alcohol intake and body weight","volume":"33","author":"Takahashi","year":"1994","journal-title":"Br J Rheumatol"},{"key":"10.1016\/j.clindermatol.2018.04.010_bb0285","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1007\/s11926-996-0043-1","article-title":"Diet, alcohol, and gout: how do we advise patients given recent developments?","volume":"7","author":"Choi","year":"2005","journal-title":"Curr Rheumatol Rep"},{"key":"10.1016\/j.clindermatol.2018.04.010_bb0290","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1002\/art.1780180704","article-title":"Port wine and the gout","volume":"18","author":"Healey","year":"1975","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.clindermatol.2018.04.010_bb0295","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1056\/NEJM198303173081123","article-title":"Saturnine gout among Roman aristocrats. Did lead poisoning contribute to the fall of the Empire?","volume":"308","author":"Nriagu","year":"1983","journal-title":"N Engl J Med"},{"key":"10.1016\/j.clindermatol.2018.04.010_bb0300","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/j.clindermatol.2006.07.015","article-title":"Metabolic diseases: gout","volume":"24","author":"Falasca","year":"2006","journal-title":"Clin Dermatol"},{"key":"10.1016\/j.clindermatol.2018.04.010_bb0305","doi-asserted-by":"crossref","DOI":"10.1136\/bcr-2013-009735","article-title":"\u2018Golden Kernels within the skin\u2019: disseminated cutaneous gout","volume":"2013","author":"Lo","year":"2013","journal-title":"BMJ Case Rep"},{"key":"10.1016\/j.clindermatol.2018.04.010_bb0310","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1016\/0002-9343(74)90639-1","article-title":"Acute polyarticular gout","volume":"56","author":"Hadler","year":"1974","journal-title":"Am J Med"},{"key":"10.1016\/j.clindermatol.2018.04.010_bb0315","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1080\/03009740310004621","article-title":"Epidemiology of extra-articular manifestations in rheumatoid arthritis","volume":"33","author":"Turesson","year":"2004","journal-title":"Scand J Rheumatol"},{"key":"10.1016\/j.clindermatol.2018.04.010_bb0320","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/0002-9343(73)90040-5","article-title":"The extra-articular features of rheumatoid arthritis. A systematic analysis of 127 cases","volume":"54","author":"Gordon","year":"1973","journal-title":"Am J Med"},{"key":"10.1016\/j.clindermatol.2018.04.010_bb0325","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1016\/j.clindermatol.2006.07.008","article-title":"Rheumatoid arthritis in dermatology","volume":"24","author":"Hata","year":"2006","journal-title":"Clin Dermatol"},{"key":"10.1016\/j.clindermatol.2018.04.010_bb0330","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/0002-9343(84)90787-3","article-title":"Rheumatoid nodules. Review of the spectrum of associated conditions and proposal of a new classification, with a report of four seronegative cases","volume":"76","author":"Kaye","year":"1984","journal-title":"Am J Med"},{"key":"10.1016\/j.clindermatol.2018.04.010_bb0335","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1097\/00005792-200107000-00006","article-title":"The HLA-DRB1*0401 allele and the development of methotrexate-induced accelerated rheumatoid nodulosis: a follow-up study of 79 Caucasian patients with rheumatoid arthritis","volume":"80","author":"Ahmed","year":"2001","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.clindermatol.2018.04.010_bb0340","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1002\/art.10535","article-title":"Accelerated nodulosis and vasculitis following etanercept therapy for rheumatoid arthritis","volume":"47","author":"Cunnane","year":"2002","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.clindermatol.2018.04.010_bb0345","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1097\/01.rhu.0000147054.26777.43","article-title":"Accelerated cutaneous nodulosis during infliximab therapy in a patient with rheumatoid arthritis","volume":"10","author":"Mackley","year":"2004","journal-title":"J Clin Rheumatol"},{"key":"10.1016\/j.clindermatol.2018.04.010_bb0350","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1046\/j.1365-2133.2002.04933.x","article-title":"Clinical and histopathological spectrum of cutaneous vasculitis in rheumatoid arthritis","volume":"147","author":"Chen","year":"2002","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.clindermatol.2018.04.010_bb0355","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1136\/ard.46.10.727","article-title":"Clinical and serological features of severe vasculitis in rheumatoid arthritis: prognostic implications","volume":"46","author":"Geirsson","year":"1987","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.clindermatol.2018.04.010_bb0360","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/0002-9343(84)90654-5","article-title":"Intravenous cyclophosphamide plus methylprednisolone in treatment of systemic rheumatoid vasculitis","volume":"76","author":"Scott","year":"1984","journal-title":"Am J Med"},{"key":"10.1016\/j.clindermatol.2018.04.010_bb0365","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1097\/00005792-198611000-00002","article-title":"Rheumatoid vasculitis: survival and associated risk factors","volume":"65","author":"Vollertsen","year":"1986","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.clindermatol.2018.04.010_bb0370","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1136\/ard.55.3.190","article-title":"Factors associated with the development of vasculitis in rheumatoid arthritis: results of a case-control study","volume":"55","author":"Voskuyl","year":"1996","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.clindermatol.2018.04.010_bb0375","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1136\/ard.26.6.475","article-title":"Clinical background of rheumatoid vascular disease","volume":"26","author":"Wilkinson","year":"1967","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.clindermatol.2018.04.010_bb0380","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1136\/ard.41.4.360","article-title":"Rheumatoid and other diseases of the cervical interspinous bursae, and changes in the spinous processes","volume":"41","author":"Bywaters","year":"1982","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.clindermatol.2018.04.010_bb0385","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1159\/000051716","article-title":"Bywater\u2019s lesions","volume":"203","author":"Boulinguez","year":"2001","journal-title":"Dermatology"},{"key":"10.1016\/j.clindermatol.2018.04.010_bb0390","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/0002-9343(61)90064-X","article-title":"Arteritis in rheumatoid arthritis","volume":"30","author":"Schmid","year":"1961","journal-title":"Am J Med"},{"key":"10.1016\/j.clindermatol.2018.04.010_bb0395","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1097\/00005792-198107000-00004","article-title":"Systemic rheumatoid vasculitis: a clinical and laboratory study of 50 cases","volume":"60","author":"Scott","year":"1981","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.clindermatol.2018.04.010_bb0400","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1136\/ard.46.9.658","article-title":"Renal findings in rheumatoid arthritis: clinical aspects of 132 necropsies","volume":"46","author":"Boers","year":"1987","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.clindermatol.2018.04.010_bb0405","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1097\/01.md.0000158825.87055.0b","volume":"84","author":"Pagnoux","year":"2005","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.clindermatol.2018.04.010_bb0410","doi-asserted-by":"crossref","first-page":"565","DOI":"10.4065\/70.6.565","article-title":"Rheumatoid vasculitis manifesting as intra-abdominal hemorrhage","volume":"70","author":"Achkar","year":"1995","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.clindermatol.2018.04.010_bb0415","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1111\/j.1572-0241.1998.119_c.x","article-title":"Gastrointestinal infarction as a manifestation of rheumatoid vasculitis","volume":"93","author":"Babian","year":"1998","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.clindermatol.2018.04.010_bb0420","first-page":"2624","article-title":"Hepatic hemorrhage in malignant rheumatoid arthritis","volume":"91","author":"Mizuno","year":"1996","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.clindermatol.2018.04.010_bb0425","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1002\/art.1780140206","article-title":"Hypocomplementemia in rheumatoid arthritis","volume":"14","author":"Franco","year":"1971","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.clindermatol.2018.04.010_bb0430","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1002\/art.1780190520","article-title":"Rheumatoid vasculitis","volume":"19","author":"Glass","year":"1976","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.clindermatol.2018.04.010_bb0435","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/0049-0172(85)90047-2","article-title":"Rheumatoid vasculitis: experience with 13 patients and review of the literature","volume":"14","author":"Schneider","year":"1985","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.clindermatol.2018.04.010_bb0440","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1136\/ard.54.11.927","article-title":"Isolated nail fold vasculitis in rheumatoid arthritis","volume":"54","author":"Watts","year":"1995","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.clindermatol.2018.04.010_bb0445","series-title":"Paper presented at: 66th Annual Scientific Meeting of the American-College-of-Rheumatology\/37th Annual Scientific Meeting of the Association-of-Rheumatology-Health-Professionals, 2002-10-24-2002-10-29","article-title":"Do we need to treat isolated nailfold vasculitis (NFV) in rheumatoid arthritis (RA) more aggressively?","author":"Price-Forbes","year":"2002"},{"key":"10.1016\/j.clindermatol.2018.04.010_bb0450","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1016\/j.berh.2016.10.008","article-title":"Vasculitis and inflammatory arthritis","volume":"30","author":"Watts","year":"2016","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"10.1016\/j.clindermatol.2018.04.010_bb0455","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1159\/000284583","article-title":"Leg ulceration in rheumatoid arthritis\u2014an underreported multicausal complication with considerable morbidity: analysis of thirty-six patients and review of the literature","volume":"220","author":"Seitz","year":"2010","journal-title":"Dermatology"},{"key":"10.1016\/j.clindermatol.2018.04.010_bb0460","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1001\/jamadermatol.2015.3029","article-title":"Risk of nonmelanoma skin cancer associated with the use of immunosuppressant and biologic agents in patients with a history of autoimmune disease and nonmelanoma skin cancer","volume":"152","author":"Scott","year":"2016","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.clindermatol.2018.04.010_bb0465","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1093\/rheumatology\/ken129","article-title":"Successful treatment of rheumatoid vasculitis-associated cutaneous ulcers using rituximab in two patients with rheumatoid arthritis","volume":"47","author":"Hellmann","year":"2008","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.clindermatol.2018.04.010_bb0470","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1016\/S0161-6420(84)34160-4","article-title":"Mortality rate in rheumatoid arthritis patients developing necrotizing scleritis or peripheral ulcerative keratitis. Effects of systemic immunosuppression","volume":"91","author":"Foster","year":"1984","journal-title":"Ophthalmology"},{"key":"10.1016\/j.clindermatol.2018.04.010_bb0475","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1097\/00003226-199507000-00010","article-title":"Destructive corneal and scleral disease associated with rheumatoid arthritis. Medical and surgical management","volume":"14","author":"Messmer","year":"1995","journal-title":"Cornea"},{"key":"10.1016\/j.clindermatol.2018.04.010_bb0480","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/S0950-3579(97)80048-9","article-title":"Vasculitis associated with connective tissue disease","volume":"11","author":"Breedveld","year":"1997","journal-title":"Baillieres Clin Rheumatol"},{"key":"10.1016\/j.clindermatol.2018.04.010_bb0485","doi-asserted-by":"crossref","first-page":"407","DOI":"10.7326\/0003-4819-93-3-407","article-title":"Rheumatoid vasculitis: effect of cyclophosphamide on the clinical course and levels of circulating immune complexes","volume":"93","author":"Abel","year":"1980","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.clindermatol.2018.04.010_bb0490","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1002\/acr.20689","article-title":"Rituximab therapy for systemic vasculitis associated with rheumatoid arthritis: results from the AutoImmunity and Rituximab Registry","volume":"64","author":"Puechal","year":"2012","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"10.1016\/j.clindermatol.2018.04.010_bb0495","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/j.jbspin.2015.08.016","article-title":"New onset of rheumatoid vasculitis during abatacept therapy and subsequent improvement after rituximab","volume":"83","author":"Carvajal Alegria","year":"2016","journal-title":"Joint Bone Spine"},{"key":"10.1016\/j.clindermatol.2018.04.010_bb0500","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1136\/ard.32.6.589","article-title":"Proceedings: Controlled trial of azathioprine in rheumatoid vasculitis","volume":"32","author":"Nicholls","year":"1973","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.clindermatol.2018.04.010_bb0505","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1056\/NEJMoa041884","article-title":"Etanercept plus standard therapy for Wegener\u2019s granulomatosis","volume":"352","author":"Wegener\u2019s Granulomatosis Etanercept Trial (WGET) Research Group","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.clindermatol.2018.04.010_bb0515","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/S0190-9622(96)90428-4","article-title":"Pyoderma gangrenosum: classification and management","volume":"34","author":"Powell","year":"1996","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2018.04.010_bb0520","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1111\/j.1365-4632.2004.02128.x","article-title":"Pyoderma gangrenosum: clinicopathologic correlation and proposed diagnostic criteria","volume":"43","author":"Su","year":"2004","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.clindermatol.2018.04.010_bb0525","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1111\/j.1365-2133.2011.10565.x","article-title":"Pyoderma gangrenosum: a retrospective review of patient characteristics, comorbidities and therapy in 103 patients","volume":"165","author":"Binus","year":"2011","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.clindermatol.2018.04.010_bb0530","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1001\/archderm.1972.01620150083026","article-title":"Bullous pyoderma gangrenosum and leukemia","volume":"106","author":"Perry","year":"1972","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.clindermatol.2018.04.010_bb0535","doi-asserted-by":"crossref","first-page":"e5","DOI":"10.1111\/j.1440-0960.2009.00614.x","article-title":"Bowel bypass syndrome\/bowel-associated dermatosis arthritis syndrome post laparoscopic gastric bypass surgery","volume":"52","author":"Tu","year":"2011","journal-title":"Australas J Dermatol"},{"key":"10.1016\/j.clindermatol.2018.04.010_bb0540","doi-asserted-by":"crossref","first-page":"191","DOI":"10.2165\/11595240-000000000-00000","article-title":"Etiology and management of pyoderma gangrenosum: a comprehensive review","volume":"13","author":"Ahronowitz","year":"2012","journal-title":"Am J Clin Dermatol"},{"key":"10.1016\/j.clindermatol.2018.04.010_bb0545","article-title":"Approach to and Management of the Neutrophilic Dermatoses","volume":"5","author":"Kurtzman","year":"2016","journal-title":"J Curr Derm Rep"},{"key":"10.1016\/j.clindermatol.2018.04.010_bb0550","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1046\/j.1365-2133.1999.02746.x","article-title":"Combination oral and topical tacrolimus in therapy-resistant pyoderma gangrenosum","volume":"140","author":"Jolles","year":"1999","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.clindermatol.2018.04.010_bb0555","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1080\/095466301750163518","article-title":"Topical tacrolimus in the management of peristomal pyoderma gangrenosum","volume":"12","author":"Lyon","year":"2001","journal-title":"J Dermatolog Treat"},{"key":"10.1016\/j.clindermatol.2018.04.010_bb0560","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1111\/j.1468-3083.2007.02280.x","article-title":"Successful treatment of severe pyoderma gangrenosum with pimecrolimus cream 1%","volume":"22","author":"Bellini","year":"2008","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.clindermatol.2018.04.010_bb0565","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1111\/j.1365-2230.1992.tb00254.x","article-title":"Pyoderma gangrenosum\u2014response to topical nitrogen mustard","volume":"17","author":"Tsele","year":"1992","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.clindermatol.2018.04.010_bb0570","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1159\/000246377","article-title":"Topical treatment with 1% sodium cromoglycate in pyoderma gangrenosum","volume":"192","author":"Tamir","year":"1996","journal-title":"Dermatology"},{"key":"10.1016\/j.clindermatol.2018.04.010_bb0575","first-page":"262","article-title":"Successful treatment of pyoderma gangrenosum with topical 5-aminosalicylic acid","volume":"51","author":"Sanders","year":"1993","journal-title":"Cutis"},{"key":"10.1016\/j.clindermatol.2018.04.010_bb0580","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1046\/j.1468-3083.2000.00019.x","article-title":"Treatment of recalcitrant ulcers in pyoderma gangrenosum with mycophenolate mofetil and autologous keratinocyte transplantation on a hyaluronic acid matrix","volume":"14","author":"Wollina","year":"2000","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.clindermatol.2018.04.010_bb0585","doi-asserted-by":"crossref","first-page":"h2958","DOI":"10.1136\/bmj.h2958","article-title":"Comparison of the two most commonly used treatments for pyoderma gangrenosum: results of the STOP GAP randomised controlled trial","volume":"350","author":"Ormerod","year":"2015","journal-title":"BMJ"},{"key":"10.1016\/j.clindermatol.2018.04.010_bb0590","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.jaad.2004.10.006","article-title":"Treatment recommendations for pyoderma gangrenosum: an evidence-based review of the literature based on more than 350 patients","volume":"53","author":"Reichrath","year":"2005","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2018.04.010_bb0595","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.jaad.2009.05.030","article-title":"Pyoderma gangrenosum: a review and update on new therapies","volume":"62","author":"Miller","year":"2010","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2018.04.010_bb0600","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1159\/000068887","article-title":"Resolution of pyoderma gangrenosum after therapy with lyophilized bovine collagen matrix","volume":"206","author":"Farris","year":"2003","journal-title":"Dermatology"},{"key":"10.1016\/j.clindermatol.2018.04.010_bb0605","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1097\/00129334-200207000-00010","article-title":"Use of becaplermin in progressive limb-threatening pyoderma gangrenosum","volume":"15","author":"Freedman","year":"2002","journal-title":"Adv Skin Wound Care"},{"key":"10.1016\/j.clindermatol.2018.04.010_bb0610","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.det.2015.03.005","article-title":"Reactive granulomatous dermatitis: a review of palisaded neutrophilic and granulomatous dermatitis, interstitial granulomatous dermatitis, interstitial granulomatous drug reaction, and a proposed reclassification","volume":"33","author":"Rosenbach","year":"2015","journal-title":"Dermatol Clin"},{"key":"10.1016\/j.clindermatol.2018.04.010_bb0615","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1001\/archderm.1994.01690100062010","article-title":"The histopathologic spectrum of palisaded neutrophilic and granulomatous dermatitis in patients with collagen vascular disease","volume":"130","author":"Chu","year":"1994","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.clindermatol.2018.04.010_bb0620","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1111\/j.1365-2133.2011.10727.x","article-title":"Interstitial granulomatous dermatitis: a distinct entity with characteristic histological and clinical pattern","volume":"166","author":"Peroni","year":"2012","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.clindermatol.2018.04.010_bb0625","doi-asserted-by":"crossref","first-page":"134","DOI":"10.7326\/0003-4819-63-1-134","article-title":"Linear subcutaneous bands in rheumatoid arthritis. an unusual form of rheumatoid granuloma","volume":"63","author":"Dykman","year":"1965","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.clindermatol.2018.04.010_bb0630","first-page":"30","article-title":"Interstitial granulomatous dermatitis associated with chronic inflammatory demyelinating polyneuropathy","volume":"90","author":"Walling","year":"2012","journal-title":"Cutis"},{"key":"10.1016\/j.clindermatol.2018.04.010_bb0635","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1067\/mjd.2001.114577","article-title":"Interstitial granulomatous dermatitis with cutaneous cords and arthritis: a disorder associated with autoantibodies","volume":"45","author":"Verneuil","year":"2001","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2018.04.010_bb0640","first-page":"661","article-title":"Interstitial granulomatous dermatitis (Ackerman\u2019s Syndrome)","volume":"20","author":"Felcht","year":"2010","journal-title":"Eur J Dermatol"},{"key":"10.1016\/j.clindermatol.2018.04.010_bb0645","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1111\/j.1365-2230.2008.02774.x","article-title":"Interstitial granulomatous dermatitis: a misdiagnosed cutaneous form of systemic lupus erythematosus?","volume":"33","author":"Blaise","year":"2008","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.clindermatol.2018.04.010_bb0650","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1111\/j.1600-0560.1998.tb01693.x","article-title":"The interstitial granulomatous drug reaction: a distinctive clinical and pathological entity","volume":"25","author":"Magro","year":"1998","journal-title":"J Cutan Pathol"},{"key":"10.1016\/j.clindermatol.2018.04.010_bb0655","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1111\/j.1365-2133.2004.05916.x","article-title":"A case of interstitial granulomatous drug reaction due to sennoside","volume":"150","author":"Fujita","year":"2004","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.clindermatol.2018.04.010_bb0660","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1111\/j.1468-3083.2009.03428.x","article-title":"Interstitial granulomatous dermatitis with arthritis associated with trastuzumab","volume":"24","author":"Martin","year":"2010","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.clindermatol.2018.04.010_bb0665","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1111\/j.1468-3083.2008.02953.x","article-title":"Interstitial granulomatous drug reaction due to thalidomide","volume":"23","author":"Yazganoglu","year":"2009","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.clindermatol.2018.04.010_bb0670","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1097\/DAD.0b013e3181c0e14d","article-title":"Allopurinol-induced DRESS syndrome with a histologic pattern consistent with interstitial granulomatous drug reaction","volume":"36","author":"Kim","year":"2014","journal-title":"Am J Dermatopathol"},{"key":"10.1016\/j.clindermatol.2018.04.010_bb0675","doi-asserted-by":"crossref","first-page":"S25","DOI":"10.1016\/j.jaad.2007.11.004","article-title":"Interstitial granulomatous drug reaction to anakinra","volume":"59","author":"Regula","year":"2008","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2018.04.010_bb0680","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1097\/DAD.0b013e3181af21b6","article-title":"Interstitial granulomatous drug reaction to adalimumab","volume":"32","author":"Martorell-Calatayud","year":"2010","journal-title":"Am J Dermatopathol"},{"key":"10.1016\/j.clindermatol.2018.04.010_bb0685","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1111\/j.1365-2133.2008.08560.x","article-title":"Interstitial granulomatous drug reaction following intravenous ganciclovir","volume":"158","author":"Marcollo Pini","year":"2008","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.clindermatol.2018.04.010_bb0690","doi-asserted-by":"crossref","first-page":"182","DOI":"10.4103\/0378-6323.129420","article-title":"Interstitial granulomatous drug reaction due to febuxostat","volume":"80","author":"Laura","year":"2014","journal-title":"Indian J Dermatol Venereol Leprol"},{"key":"10.1016\/j.clindermatol.2018.04.010_bb0695","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1093\/rheumatology\/33.11.1078","article-title":"Leg ulceration in rheumatoid arthritis","volume":"33","author":"McRorie","year":"1994","journal-title":"Br J Rheumatol"},{"key":"10.1016\/j.clindermatol.2018.04.010_bb0700","doi-asserted-by":"crossref","first-page":"35","DOI":"10.7326\/0003-4819-120-1-199401010-00006","article-title":"Incidence of cancer among men with the Felty syndrome","volume":"120","author":"Gridley","year":"1994","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.clindermatol.2018.04.010_bb0705","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/S0140-6736(09)60883-7","article-title":"Gout","volume":"375","author":"Richette","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.clindermatol.2018.04.010_bb0710","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1002\/art.1780261120","article-title":"Gout in Heberden\u2019s nodes","volume":"26","author":"O\u2019Dell","year":"1983","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.clindermatol.2018.04.010_bb0715","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1002\/art.1780260116","article-title":"Gout in Heberden\u2019s nodes","volume":"26","author":"Simkin","year":"1983","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.clindermatol.2018.04.010_bb0720","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1136\/ard.46.1.72","article-title":"Gout in the elderly, a separate entity?","volume":"46","author":"ter Borg","year":"1987","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.clindermatol.2018.04.010_bb0725","first-page":"137","article-title":"Histopathophysiology of gout","volume":"73","author":"Hugle","year":"2016","journal-title":"Ther Umsch"},{"key":"10.1016\/j.clindermatol.2018.04.010_bb0730","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.amjmed.2006.02.044","article-title":"Updates in the management of gout","volume":"120","author":"Keith","year":"2007","journal-title":"Am J Med"},{"key":"10.1016\/j.clindermatol.2018.04.010_bb0735","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1097\/00000372-198708000-00007","article-title":"Gout presenting as lobular panniculitis","volume":"9","author":"LeBoit","year":"1987","journal-title":"Am J Dermatopathol"}],"container-title":["Clinics in Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0738081X18300695?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0738081X18300695?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,7,5]],"date-time":"2024-07-05T21:55:48Z","timestamp":1720216548000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0738081X18300695"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,7]]},"references-count":146,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2018,7]]}},"alternative-id":["S0738081X18300695"],"URL":"https:\/\/doi.org\/10.1016\/j.clindermatol.2018.04.010","relation":{},"ISSN":["0738-081X"],"issn-type":[{"value":"0738-081X","type":"print"}],"subject":[],"published":{"date-parts":[[2018,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Inflammatory arthritis and crystal arthropathy: Current concepts of skin and systemic manifestations","name":"articletitle","label":"Article Title"},{"value":"Clinics in Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clindermatol.2018.04.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}